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Background 
In Finland, milk samples are tested for bacteria in 
most mastitis cases. Since 2010, the majority of 
samples have been analyzed using a semi-
quantitative PCR test. The test targets the DNA of 15 
bacterial species or groups of species and the 
staphylococcal blaZ gene coding for penicillin 
resistance. 
Methods 
We analyzed bacteriological data consisting of 240,069 
quarter milk samples sent to Valio Laboratory in 
2010−2012. The samples were taken from 93,530 
individual dairy cows on 4,725 dairy farms. The data 
containing records of milk samples were merged with the 
data from the Finnish dairy herd recording system. 
Descriptive statistical analyses were implemented to 
describe the results of PCR tests and the differences in 
the treatment history of cows with diverse findings from 
their milk samples. This study focuses on treatments 
associated with the findings of Staphylococcus (S.) aureus 
(n = 43,400) and coagulase-negative staphylococci (CNS) 
(n = 107,749) in milk samples. The differences between 
the treatments of penicillin-susceptible and penicillin-
resistant staphylococci were examined.  
Conclusions 
Testing the samples of mastitic milk provides valuable information for dairy farmers' decision-making. Knowing 
whether mastitis is caused e.g. by CNS vs. S. aureus or penicillin-susceptible vs. penicillin-resistant staphylococci, 
helps to assess the utility of treatments. S. aureus mastitis is treated more frequently than CNS mastitis that is often 
subclinical or mild clinical. Generally, the share of treated cows is higher with penicillin-susceptible staphylococci 
compared to penicillin-resistant staphylococci which, in turn, cause more repeated treatments. These treatments of 
mastitis having inferior cure rates compared to those of mastitis caused by penicillin-susceptible staphylococci 
should be avoided. Dairy producers seem to follow the recommendation to cull cows with chronic S. aureus mastitis 
and cows with penicillin-resistant staphylococci. By differentiation the treatments pathogen-specifically even more 
precisely than at present, dairy farmers can contribute to reducing the use of antibiotics. 
Results in figures 
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Pathogen BlaZ gene CNS S. aureus 
CNS S. aureus positive negative 
blaZ gene 
positive 
blaZ gene 
negative 
blaZ gene 
positive 
blaZ gene 
negative 
Prevalence in milk samples  46%1 18%1 31%² 69%² 30%² 70%² 32%² 68%² 
Share of treated cows 47%1 53%1 48%1 49%1 48%1 47%1 47%1 56%1 
Share of culled cows 80%1 85%1 85%1 80%1 83%1 79%1 89%1 84%1 
Mastitis as culling reason 37%1 50%1 46%1 39%1 40%1 36%1 57%1 46%1 
Photo: Aino Wathén 
1Chi-square test for equality of the two proportions on the same line of each column (p < 0.01) , ²Chi-square goodness of fit test for the proportion of 0.5 (p < 0.01)  
